Endogenous opioid system: a promising target for future smoking cessation medications
Sign Up to like & getrecommendations! Published in 2017 at "Psychopharmacology"
DOI: 10.1007/s00213-017-4582-0
Abstract: BackgroundNicotine addiction continues to be a health challenge across the world. Despite several approved medications, smokers continue to relapse. Several human and animal studies have evaluated the role of the endogenous opioid system as a… read more here.
Keywords: cessation medications; endogenous opioid; opioid system; smoking cessation ... See more keywords
Capsule Commentary on Anthenelli et al., Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial
Sign Up to like & getrecommendations! Published in 2019 at "Journal of General Internal Medicine"
DOI: 10.1007/s11606-019-04909-8
Abstract: P sychiatric symptoms are more common among individuals who smoke than among the general population, and are of potential concern to clinicians when patients attempt to quit. This study by Anthenelli et al., a secondary… read more here.
Keywords: risk; cessation medications; cessation; history ... See more keywords
Impact of Smoking and Smoking Cessation Medications in Aviators
Sign Up to like & getrecommendations! Published in 2019 at "Current Psychiatry Reports"
DOI: 10.1007/s11920-019-1109-x
Abstract: To (1) compare the effects of cigarette smoking, nicotine withdrawal, and smoking cessation medications in US civilian and military aviators and (2) review the regulations in place regarding the use of smoking cessation medications for… read more here.
Keywords: cessation medications; medications aviators; civilian military; smoking cessation ... See more keywords